Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...
They're about to learn what hedge-fund investor Jim Simons proved in 1988: Having the same tools as a genius doesn't make you a genius.
Kinesin-1 is a dynamic heterotetrameric assembly of two heavy and two light chains (KHC and KLC) that mediates microtubule-based intracellular transport of many different cargoes. The complex adopts a ...
Shift verification effort from a single, time-consuming flat run to a more efficient, distributed, and scalable process.
The fun part about a programming language like C is that although the language doesn’t directly support many features including object-oriented programming and generics, there’s ...